LUXERA BIOTECH LABS

,

Blend BPC-157 + TB-500

Price range: $99.00 through $129.00

BPC-157 + TB-500 Blend is a dual-peptide research formulation combining a gastric pentadecapeptide with a Thymosin Beta-4 fragment. Investigated in preclinical models for complementary roles in VEGF-mediated angiogenesis, actin-regulated cellular migration, and extracellular matrix remodeling across musculoskeletal and vascular research applications.

SKU: N/A Categories: ,

What Is BPC-157 + TB-500 Blend?
BPC-157 + TB-500 Blend is a dual-peptide research formulation combining Body Protection Compound-157 — a synthetic pentadecapeptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) first isolated from gastric mucosal extracts in the 1990s — with TB-500, a synthetic analog of the actin-sequestering Thymosin Beta-4 protein. The combination is formulated to engage two distinct but complementary molecular pathways simultaneously within preclinical tissue repair research models.

Mechanism of Action
BPC-157 operates via upregulation of Vascular Endothelial Growth Factor (VEGF) and Early Growth Response-1 (EGR-1), initiating angiogenic signaling and extracellular matrix scaffolding. It additionally activates FAK/paxillin signaling pathways, modulating focal adhesion dynamics in fibroblast populations. TB-500 functions through G-actin sequestration and interaction with the Arp2/3 protein complex, facilitating cytoskeletal reorganization and directional cell migration toward injury sites. Angiogenic activity of TB-500 is further associated with Notch signaling pathway modulation, regulating endothelial cell fate and vascular development. Together, these pathways coordinate complementary phases of the tissue repair cascade at the extracellular matrix level.

Research Applications
In preclinical and in vitro settings, this blend is investigated for:

  • Musculoskeletal injury models — tendon, ligament, and muscle repair pathway analysis
  • Angiogenesis studies — examining VEGF and Notch-driven vascular formation
  • Cellular migration research — assessing actin polymerization and fibroblast directional movement
  • Inflammatory response modulation — studying cytokine activity and healing cascade regulation

Purity & Quality
Each component synthesized to ≥98% purity, verified by HPLC and mass spectrometry. Batch-specific Certificate of Analysis provided. All referenced data is derived from in vitro and preclinical animal studies.

BPC-157 Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | MW: 1419.53 g/mol | TB-500 MW: 4963.44 g/mol | Storage: -20°C lyophilized; 2–8°C post-reconstitution

Select mg

5mg + 5mg, 10mg + 10mg

Reviews

There are no reviews yet.

Be the first to review “Blend BPC-157 + TB-500”

Your email address will not be published. Required fields are marked *

Scroll to Top